Anticancer Repurposing
Anticancer Repurposing is a research paradigm within natural product repurposing that identifies and validates existing non-cancer bioactive compounds for new therapeutic applications in oncology through systematic biological or computational analysis.
378
Publications
18.9K
Citations
2.4K
Authors
817
Institutions
Publications per year
2017–2026
237
Parents
378
Discovering the anticancer potential of non-oncology drugs by systematic viability profiling
Steven M. Corsello, Rohith T. Nagari, Ryan D. Spangler et al. · Nature Cancer · 2020 · 883 citations · Full text
Medicine, Oncology, Pharmacology +13
Splicing factor SF3b as a target of the antitumor natural product pladienolide
Yoshihiko Kotake, Koji Sagane, Takashi Owa et al. · Nature Chemical Biology · 2007 · 659 citations · Full text
Application of ferrocene and its derivatives in cancer research
Cátia Ornelas · New Journal of Chemistry · 2011 · 471 citations
1–5 of 378
2.4K
9
h-index
6
h-index
5
h-index
National Center for Advancing Translational Sciences, United States
5 publications · 240 citations
5
h-index
5
h-index
1–5 of 2.4K
817
Anticancer Fund
Grimbergen, Belgium
8 h-index
26 publications
2.7K citations
Harvard University
Cambridge, United States
7 h-index
26 publications
4K citations

King Saud University
Riyadh, Saudi Arabia
7 h-index
15 publications
484 citations
The George Institute for Global Health
London, United Kingdom
6 h-index
6 publications
458 citations
Emory University
Atlanta, United States
6 h-index
24 publications
4.3K citations

Al-Azhar University
Cairo, Egypt
6 h-index
23 publications
788 citations

Sichuan University
Chengdu, China
6 h-index
29 publications
1.3K citations
National Research Centre
Giza, Egypt
6 h-index
9 publications
311 citations
1–8 of 817
17 publications · 1.1K citations
15
h-index
9 publications · 496 citations
9
h-index
10 publications · 263 citations
9
h-index
9 publications · 841 citations
9
h-index
8 publications · 299 citations
8
h-index
1–5